The latest update is out from Amur Minerals ( ($GB:CRTX) ). CRISM Therapeutics has raised £2.5 million in a significantly oversubscribed placing of......

Tpg Re Finance ( ($TRTX) ) has provided an update. At its May 19, 2026 annual meeting of stockholders, TPG RE Finance Trust shareholders elected ei......

Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. This Phase 2 study, officially titled “A Phase 2, Multicen......

Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. This Phase 2 study, officially titled “A Phase 2, Multicen......

Gina Rinehart, Australian billionaire mining magnate, is upping her stakes in U.S. defense companies with almost $100 million. A document submitted......

Last week, stocks pulled back from record highs as oil, yields, and rate fears returned to the forefront. The S&P 500 (SPX) ended at 7,408.50, down......

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ALX Oncology Holdings (ALXO) and Heron Therapeutic......

Vanguard S&P 500 ETF ($VOO) remains one of the most popular choices for investors seeking broad exposure to the U.S. stock market. However, as mark......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Editas Medicine (EDIT), Vertex Pharmaceuticals (VRTX......

RBC Capital analyst Brian Abrahams maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $543.00. The company’s sha......